Developing a xenograft human tumor model in immunocompetent mice.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Cancer Letters

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.canlet.2017.10.009PMID 29054784
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An immunocompetent mouse model of human glioblastoma

  2017cited by this paper
• [Immunotherapy for Bladder Cancer].

  2017cited by this paper
• In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers.

  2017cited by this paper
• Nanoparticles for tumor immunotherapy

  2017cited by this paper
• Prospects for gene-engineered T cell immunotherapy for solid cancers

  2016cited by this paper
• New targeted therapies in pancreatic cancer.

  2015cited by this paper
• Immune Therapy in GI Malignancies: A Review.

  2015cited by this paper
• Partial rescue of mucopolysaccharidosis type VII mice with a lifelong engraftment of allogeneic stem cells in utero

  2015cited by this paper
• Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer

  2013cited by this paper
• Patient-derived tumour xenografts as models for oncology drug development

  2012cited by this paper
• Human Tumor Xenograft Efficacy Models

  2011cited by this paper
• Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice.

  2008cited by this paper
• Contributions of human tumor xenografts to anticancer drug development.

  2006cited by this paper
• Mouse models in oncogenesis and cancer therapy

  2006cited by this paper
• Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

  2005cited by this paper
• Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.

  2004cited by this paper
• Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion.

  2002cited by this paper
• Critical windows in development of the rodent immune system

  2002influential reference
• Characterization of the human antiporcine immune response

  1999cited by this paper
• The Physiological Role of Regulatory T Cells in the Prevention of Autoimmunity: the Function of the Thymus in the Generation of the Regulatory T Cell Subset

  1996cited by this paper
• Lymphocytes selected in allogeneic thymic epithelium mediate dominant tolerance toward tissue grafts of the thymic epithelium haplotype.

  1995cited by this paper
• The role of the T cell receptor in positive and negative selection of developing T cells.

  1990cited by this paper
• Positive and negative selection of an antigen receptor on T cells in transgenic mice

  1988cited by this paper
• Theoretical Biology and Medical Modelling Open Access an Immune Reaction May Be Necessary for Cancer Development

  year unknowncited by this paper

• Hormone Signaling in Breast Development and Cancer.

  2025cites this paper
• From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies

  2024cites this paper
• Redox phospholipidomics discovers pro-ferroptotic death signals in A375 melanoma cells in vitro and in vivo

  2023cites this paper
• What Are the Reasons for Continuing Failures in Cancer Therapy? Are Misleading/Inappropriate Preclinical Assays to Be Blamed? Might Some Modern Therapies Cause More Harm than Benefit?

  2022cites this paper
• Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer

  2022cites this paper
• Immunodeficient and Humanized Mice

  2021cites this paper
• Orthotopic grafts of human malignant gliomas: history, technologies, achievements and problems

  2020cites this paper
• Relevance of humanized three-dimensional tumor tissue models: a descriptive systematic literature review

  2020cites this paper
• Establishment of a Human Gastric Cancer Xenograft Model in Immunocompetent Mice Using the Microcarrier-6

  2020cites this paper
• Conditional reprograming culture conditions facilitate growth of lower grade glioma models.

  2020cites this paper
• Accelerated elimination of human cancer cells by a CD40 agonist antibody combined with a PD-1 antagonist in CD4-depleted mice

  2019cites this paper
• A InIII -MOF with Imidazole Decorated Pores as 5-Fu Delivery System to Inhibit Colon Cancer Cells Proliferation and Induce Cell Apoptosis in vitro and in vivo

  2019cites this paper
• Exploring signaling pathways and pancreatic cancer treatment approaches using genetic models.

  2019cites this paper
• Patient-derived xenograft models in musculoskeletal malignancies

  2018cites this paper
• Plasma, cancer, immunity

  2018cites this paper
• Murine models of melanoma.

  2018cites this paper